Alyeska Investment Group, L.P. Rain Therapeutics Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.77 - $12.47 $582,750 - $935,250	75,000 Added 60.0%	200,000 $1.75 Million
Q4 2021 Feb 14, 2022	SELL	$11.91 - $17.0 $85,108 - $121,482	-7,146 Reduced 5.41%	125,000 $1.61 Million
Q3 2021 Nov 15, 2021	SELL	$13.21 - $20.91 $566,101 - $896,077	-42,854 Reduced 24.49%	132,146 $1.98 Million
Q2 2021 Aug 16, 2021	BUY	$15.08 - $20.3 $2.64 Million - $3.55 Million	175,000 New	175,000 $2.72 Million

122K

Ticker RAIN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,837,400
Description
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.